| Breakdown | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 49.90M | 35.20M | 202.20M | 371.70M | 154.70M |
| Gross Profit | 49.90M | 35.10M | 202.30M | 371.80M | 154.80M |
| EBITDA | 45.90M | 66.80M | 198.40M | 368.70M | 151.90M |
| Net Income | 45.90M | 30.50M | 198.40M | 368.70M | 151.90M |
Balance Sheet | |||||
| Total Assets | 3.03B | 3.21B | 3.35B | 3.16B | 2.95B |
| Cash, Cash Equivalents and Short-Term Investments | 700.00K | 1.10M | 1.00M | 1.20M | 400.00K |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 1.80M | 900.00K | 1.10M | 800.00K | 700.00K |
| Stockholders Equity | 3.03B | 3.21B | 3.35B | 3.16B | 2.95B |
Cash Flow | |||||
| Free Cash Flow | 126.90M | 167.70M | 165.20M | 160.60M | 157.90M |
| Operating Cash Flow | 126.90M | 167.70M | 165.20M | 160.60M | 157.90M |
| Investing Cash Flow | 100.00M | 0.00 | -157.90M | 0.00 | -118.40M |
| Financing Cash Flow | -227.30M | -167.60M | -7.50M | -159.80M | -39.70M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | £9.02B | 11.95 | 12.35% | 5.37% | 4.78% | -4.86% | |
73 Outperform | £411.93M | 7.48 | 44.99% | 5.73% | ― | ― | |
70 Outperform | ― | 5.04 | ― | 7.20% | 44.39% | 20.63% | |
67 Neutral | £4.58B | 5.37 | 23.35% | 4.13% | 28.34% | 44.04% | |
65 Neutral | £262.65M | -1.21 | -6.58% | 8.18% | -9.72% | -25.25% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
44 Neutral | ― | -1.48 | -47.36% | 3.45% | ― | ― |